Home / Publications / Emerging Viruses

Emerging Viruses

Publications related to emerging viruses by MARCE participants.

  • Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, and Broder CC: Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 2005, 102: 10652-10657 PubMed link

  • Bossart KN and Broder CC: Developments towards effective treatments for Nipah and Hendra virus infection. Expert Rev Anti Infect Ther 2006, 4: 43-55 PubMed link

  • Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, and Broder CC: Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol 2005, 79: 6690-6702 PubMed link

  • Carrion R, Jr., Brasky K, Mansfield K, Johnson C, Gonzales M, Ticer A, Lukashevich I, Tardif S, and Patterson J: Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol 2007, 81: 6482-6490 PubMed link

  • Carrion R, Jr., Patterson JL, Johnson C, Gonzales M, Moreira CR, Ticer A, Brasky K, Hubbard GB, Moshkoff D, Zapata J, Salvato MS, and Lukashevich IS: A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine 2007, 25: 4093-4102 PubMed link

  • Davis CW, Mattei LM, Nguyen HY, Ansarah-Sobrinho C, Doms RW, and Pierson TC: The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J Biol Chem 2006, 281: 37183-37194 PubMed link

  • Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, and Pierson TC: West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol 2006, 80: 1290-1301 PubMed link

  • Durbin AP, McArthur JH, Marron JA, Blaney JE, Thumar B, Wanionek K, Murphy BR, and Whitehead SS: rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naive adults. Hum Vaccin 2006, 2: 255-260 PubMed link

  • Eaton BT, Broder CC, Middleton D, and Wang LF: Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 2006, 4: 23-35 PubMed link

  • Eaton BT, Broder CC, and Wang LF: Hendra and Nipah viruses: pathogenesis and therapeutics. Curr Mol Med 2005, 5: 805-816 PubMed link

  • Filone CM, Heise M, Doms RW, and Bertolotti-Ciarlet A: Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology 2006, 356: 155-164 PubMed link

  • Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, and Doms RW: N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J Virol 2005, 79: 13262-13274 PubMed link

  • Hofmann H, Simmons G, Rennekamp AJ, Chaipan C, Gramberg T, Heck E, Geier M, Wegele A, Marzi A, Bates P, and Pohlmann S: Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol 2006, 80: 8639-8652 PubMed link

  • Kaletsky RL, Simmons G, and Bates P: Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 2007, 81: 13378-13384 PubMed link

  • Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, Lingappa VR, and Pohlmann S: The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J Virol 2006, 80: 6305-6317 PubMed link

  • McCarthy SE, Licata JM, and Harty RN: A luciferase-based budding assay for Ebola virus. J Virol Methods 2006, 137: 115-119 PubMed link

  • Moshkoff DA, Salvato MS, and Lukashevich IS: Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. Virus Genes 2007, 34: 169-176 PubMed link

  • Mueller NH, Yon C, Ganesh VK, and Padmanabhan R: Characterization of the West Nile virus protease substrate specificity and inhibitors. Int J Biochem Cell Biol 2007, 39: 606-614 PubMed link

  • Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, and Broder CC: Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol 2006, 80: 12293-12302 PubMed link

  • Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, Eaton BT, and Broder CC: Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat. J Infect Dis 2007, 196: 812-816 PubMed link

  • Patch JR, Crameri G, Wang LF, Eaton BT, and Broder CC: Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J 2007, 4: 1 PubMed link

  • Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, Samuel MA, Hanna SL, Puffer BA, and Doms RW: An infectious West Nile Virus that expresses a GFP reporter gene. Virology 2005, 334: 28-40 PubMed link

  • Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss B, Valentine LE, Altamura LD, Diamond MD, and Doms RW: A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile Virus infection. Virology 2006, 346:53-65 PubMed link

  • Sanchez MD, Pierson TC, Degrace MM, Mattei LM, Hanna SL, Del Piero F, and Doms RW: The neutralizing antibody response against West Nile virus in naturally infected horses. Virology 2007, 359: 336-348 PubMed link

  • Sanchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, and Doms RW: Characterization of neutralizing antibodies to West Nile virus. Virology 2005, 336: 70-82 PubMed link

  • Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, and Bates P: Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 2004, 101: 4240-4245 PubMed link

  • Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, and Bates P: Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 2005, 102: 11876-11881 PubMed link

  • Simmons G, Rennekamp AJ, and Bates P: Proteolysis of SARS-associated coronavirus spike glycoprotein. Adv Exp Med Biol 2006, 581: 235-240 PubMed link

  • Whitby K, Pierson TC, Geiss B, Lane K, Engle M, Zhou Y, Doms RW, and Diamond MS: Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol 2005, 79: 8698-8706 PubMed link

  • Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, and Dimitrov DS: Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol 2006, 80: 891-899 PubMed link

  • Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, and Dimitrov DS: Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert Rev Anti Infect Ther 2006, 4: 57-66 PubMed link